1Steinberg M.Dasatinib:A Tyrosine kinase inhibitor for the treatment of chronic Myelogenous Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia [J].Clinical therapeutics,2007,29(11):2289-2308.
2Quintas-Cardama A,Kantarjian H,Cortes J.Flying under the radar;the new wave of BCR-ABL inhibitors[J].Nat Rev Drug Discov,2007,6(10):834-848.
3Cannel E. Dasatinib is effective in imatinib-resistant CML[J]. Lancet Oncal,2007,8(4):286.
4Francis Lee,Abderrahim Fandi,Maurizio Voi,Overcoming kinase resistance in chronic myeloid Leukemia[J].The International Journal of Biochemistry & Cell Biology,2008,40:334- 343.
